Feedback / Questions
lorecivivint (SM04690) - Biosplice Therap, Samil Pharma
https://www.manilatimes.net/2026/01/06/tmt-newswire/globenewswire/biosplice-announces-the-submission-of-its-new-drug-application-nda-to-the-fda-for-lorecivivint-lor-to-treat-knee-osteoarthritis/2253494
Jan 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next